07/15/2025
10:15 AM | Inhibikase Therapeutics (Issuer)
Sands Capital Alternatives, LLC (Reporting)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
SANDS FRANK M. (Reporting)
| Form 3/A | |
07/02/2025
6:55 PM | Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4/A | |
07/02/2025
6:56 PM | Inhibikase Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4/A | |
07/02/2025
7:00 PM | Cabell Christopher (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4/A | |
07/02/2025
6:38 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:40 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:41 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:43 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:48 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:49 PM | Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2025
11:15 PM | Inhibikase Therapeutics (Filer)
| Form EFFECT | |
Get the Latest News and Ratings for IKT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/20/2025
4:06 PM | Inhibikase Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2025
4:29 PM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
4:06 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:05 PM | Inhibikase Therapeutics (Filer)
| Form PRE 14A | |
04/14/2025
7:16 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
4:01 PM | Inhibikase Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
7:14 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
7:16 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:18 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:19 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:24 PM | Inhibikase Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/19/2025
7:26 PM | Inhibikase Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:00 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:06 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4/A | |
02/19/2025
7:11 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:11 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:09 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:04 PM | ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/14/2025
4:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Inhibikase Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
3:06 PM | Inhibikase Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/29/2025
3:05 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:05 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:05 PM | Inhibikase Therapeutics (Issuer)
Werner Milton H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:05 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:05 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
11:15 PM | Inhibikase Therapeutics (Filer)
| Form EFFECT | |
01/10/2025
3:37 PM | Inhibikase Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/07/2025
5:39 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:43 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s national nightmare is here (Ad) Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II.
They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. Watch the National Emergency broadcast here |
01/07/2025
5:47 PM | Inhibikase Therapeutics (Issuer)
Werner Milton H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:38 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:06 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
11:15 PM | Inhibikase Therapeutics (Filer)
| Form EFFECT | |
12/05/2024
3:47 PM | Inhibikase Therapeutics (Filer)
| Form 424B3 | |
12/05/2024
3:50 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
5:24 AM | Inhibikase Therapeutics (Filer)
| Form S-3/A | |
11/18/2024
3:49 PM | Inhibikase Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
7:30 AM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
3:07 PM | Inhibikase Therapeutics (Filer)
| Form PRE 14A | |
10/28/2024
4:26 PM | Inhibikase Therapeutics (Subject)
SP IKT Holdings LLC (Filed by)
| Form SC 13G | |
10/28/2024
3:00 PM | Inhibikase Therapeutics (Subject)
Soleus Private Equity Fund III, L.P. (Filed by)
| Form SC 13G | |
10/25/2024
4:52 PM | Inhibikase Therapeutics (Issuer)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
Sands Capital Ventures, LLC (Reporting)
SANDS FRANK M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2024
4:50 PM | Inhibikase Therapeutics (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
| Form SC 13G | |
10/23/2024
6:58 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:35 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:36 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:38 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:40 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:43 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:49 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:53 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:15 PM | Inhibikase Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/21/2024
8:13 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
6:00 PM | Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
| Form SC 13G | |
10/17/2024
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Inhibikase Therapeutics (Subject)
| Form SC 13G | |
10/10/2024
4:31 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:40 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
8:21 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
